Novavax (NVAX) Files for Provisional Approval of its COVID-19 Vaccine in New Zealand

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. USO
2. META
3. NVDA
4. DCOY
5. SPY
6. MSFT
7. VKTX
8. PRGS
9. CMPX
10. GS

Go back to Novavax (NVAX) Files for Provisional Approval of its COVID-19 Vaccine in New Zealand
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.83 +0.42 (4.03%)
Previous Close $10.41    52 Week High $9.23 
Open $10.39    52 Week Low $1.16 
Day High $11.09    P/E N/A 
Day Low $10.15    EPS $-0.30 
Volume 7,579,936